Clinical Conditions Associated With Cardiovascular Disease

Clinical Conditions Associated With Cardiovascular Disease

LabCorp offers tests that can help diagnose and identify the underlying causes of conditions frequently associated with the development of cardiovascular disease (CVD), such as dyslipidemia, atherosclerosis, and familial hypercholesterolemia.

 

Test Name

Test N°

Comments

*National Heart, Lung, and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 2001. NIH Publication 01-3670.

Dyslipidemia

Lipid Cascade

361946

Reflexes to lipoprotein analysis by nuclear magnetic resonance (NMR) when LDL-C is <130 mg/dL.

Lipid Panel plus

303756

Order Apolipoprotein B or NMR LipoProfile® indicated in addition to Lipid Panel.

Apolipoprotein B or

167015

NMR LipoProfile® Without Lipids (Without Graph)

884318

Secondary Dyslipidemia

(Rule out common causes: diabetes, hypothyroidism, liver disease, renal disease*)

Alanine Aminotransferase (ALT/SGPT)

001545

Drugs such as progestins, anabolic steroids, and corticosteroids increase LDL cholesterol and decrease HDL cholesterol and are also causes of secondary dyslipidemia.*

Aspartate Aminotransferase (AST/SGOT)

001123

Glomerular Filtration Rate, Estimated (eGFR)

100768

Glucose, Plasma

001818

Hemoglobin (Hb) A1c

001453

Microalbumin:Creatinine Ratio, Random Urine

140285

Renal Function Panel

322777

Thyroid-stimulating Hormone (TSH)

004259

Atherosclerosis / Inflammation

C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment)

120766

  

Fibrinogen Activity

001610

  

Fibrinogen Antigen

117052

  

Homocyst(e)ine, Plasma

706994

  

Lipoprotein (a)

120188

  

Plasminogen Activator Inhibitor (PAI-1) Activity

146787

  

Sedimentation Rate, Modified Westergen

005215